Skip to main content

Advertisement

Table 2 Comparison of gestational glucose tolerance groups at 3-years postpartum

From: Rising plasminogen activator inhibitor-1 and hypoadiponectinemia characterize the cardiometabolic biomarker profile of women with recent gestational diabetes

At 3-years postpartum Normal GCT NGT Abnormal GCT NGT GIGT GDM P
BMI (kg/m2) 25.5 ± 4.5 25.3 ± 4.9 26.6 ± 4.8 26.8 ± 6.1 0.15
Waist circumference (cm) 88 ± 12 86 ± 12 89 ± 12 90 ± 13 0.15
A1c (%) 5.4 ± 0.3 5.5 ± 0.3 5.6 ± 0.3 5.6 ± 0.4 0.0001
Fasting glucose on OGTT (mmol/L) 4.6 ± 0.4 4.6 ± 0.5 4.8 ± 0.5 4.9 ± 0.6 < 0.0001
2-h glucose on OGTT (mmol/L) 5.5 ± 1.2 6.1 ± 1.7 6.6 ± 2.1 7.4 ± 2.2 < 0.0001
Current glucose tolerance status < 0.0001
 Normal (%) 93.4 85.9 79.7 63.8  
 Pre-diabetes/diabetes (%) 6.6 14.1 20.3 36.2  
Adiponectin (μg/mL) 10.4 ± 4.6 10.1 ± 4.0 8.3 ± 3.6 8.6 ± 3.1 0.0003
Chemerin (ng/mL) 58.4 ± 14.0 59.7 ± 14.0 61.6 ± 13.7 59.9 ± 13.7 0.62
RBP-4 (mg/L) 39.7 ± 15.1 45.5 ± 18.4 42.2 ± 13.2 43.4 ± 18.0 0.16
CRP (mg/L) 1.1 (0.4–2.3) 0.9 (0.5–1.9) 1.0 (0.4–2.9) 1.5 (0.6–3.0) 0.09
PAI-1 (pg/mL) 7445 (6989–7724) 7366 (7109–7601) 7473 (7140–7654) 7446 (7193–7649) 0.43
  1. P-values refer to overall comparison across the 4 groups by either one-way analysis of variance or Kruskal–Wallis test for continuous variables, or either χ2 or Fisher exact test for categorical variables. Italic indicates P < 0.05